BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23425646)

  • 21. [Evaluation of visceral adipose in abdominal obesity and its clinical application].
    Pu YF; He HB; Zhao ZG; Chen J; Ni YX; Zhong J; Liu HY; Yan ZC; Zhu ZM
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(34):2391-4. PubMed ID: 19087712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimation of visceral fat and fatty liver disease using ultrasound in patients with diabetes.
    Onitsuka Y; Takeshima F; Ichikawa T; Kohno S; Nakao K
    Intern Med; 2014; 53(6):545-53. PubMed ID: 24633023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current diagnostic methods of the specific distribution of adipose tissue].
    Ivković-Lazar T
    Med Pregl; 2000; 53(11-12):584-7. PubMed ID: 11320744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compartmental fat distribution in the abdomen of dogs relative to overall body fat composition.
    Turner RBS; Tyrrell D; Hepworth G; Dunshea FR; Mansfield CS
    BMC Vet Res; 2020 Mar; 16(1):104. PubMed ID: 32228685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of visceral fat measurement by dual-energy X-ray absorptiometry to computed tomography in HIV and non-HIV.
    Fourman LT; Kileel EM; Hubbard J; Holmes T; Anderson EJ; Looby SE; Fitch KV; Feldpausch MN; Torriani M; Lo J; Stanley TL; Grinspoon SK
    Nutr Diabetes; 2019 Feb; 9(1):6. PubMed ID: 30804324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reliability of anthropometric parameters in the prediction of the visceral fat area among adult women.
    Pintér Z; Molnár A; Szász A; Kiss G; Orbán K; Varga C; László F; Molnár E; Pálfi G
    Anthropol Anz; 2013; 70(2):147-64. PubMed ID: 23980389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of Visceral Fat, Abdominal Circumference and Waist-hip Ratio to Predict Health Risk in Males and Females.
    Ibrahim Q; Ahsan M
    Pak J Biol Sci; 2019 Jan; 22(4):168-173. PubMed ID: 31930817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visceral fat is an independent predictor of all-cause mortality in men.
    Kuk JL; Katzmarzyk PT; Nichaman MZ; Church TS; Blair SN; Ross R
    Obesity (Silver Spring); 2006 Feb; 14(2):336-41. PubMed ID: 16571861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal permeability is associated with visceral adiposity in healthy women.
    Gummesson A; Carlsson LM; Storlien LH; Bäckhed F; Lundin P; Löfgren L; Stenlöf K; Lam YY; Fagerberg B; Carlsson B
    Obesity (Silver Spring); 2011 Nov; 19(11):2280-2. PubMed ID: 21852815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity, Visceral Fat, and Hypertension-Related Complications.
    Haberka M; Stolarz-Skrzypek K; Biedroń M; Szóstak-Janiak K; Partyka M; Olszanecka-Glinianowicz M; Gąsior Z
    Metab Syndr Relat Disord; 2018 Dec; 16(10):521-529. PubMed ID: 30183499
    [No Abstract]   [Full Text] [Related]  

  • 31. Waist circumference, dual-energy X-ray absortiometrically measured abdominal adiposity, and computed tomographically derived intra-abdominal fat area on detecting metabolic risk factors in obese women.
    Lee K; Lee S; Kim YJ; Kim YJ
    Nutrition; 2008; 24(7-8):625-31. PubMed ID: 18485667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of rosiglitazone on body composition, hepatic fat, fatty acids, adipokines and glucose in persons with impaired fasting glucose or impaired glucose tolerance: a sub-study of the DREAM trial.
    Punthakee Z; Alméras N; Després JP; Dagenais GR; Anand SS; Hunt DL; Sharma AM; Jung H; Yusuf S; Gerstein HC
    Diabet Med; 2014 Sep; 31(9):1086-92. PubMed ID: 24890138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Correlation Between Body Fat, Visceral Fat, and Nonalcoholic Fatty Liver Disease.
    Ko YH; Wong TC; Hsu YY; Kuo KL; Yang SH
    Metab Syndr Relat Disord; 2017 Aug; 15(6):304-311. PubMed ID: 28481662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishing computed tomography-defined visceral fat area thresholds for use in obesity-related cancer research.
    Doyle SL; Bennett AM; Donohoe CL; Mongan AM; Howard JM; Lithander FE; Pidgeon GP; Reynolds JV; Lysaght J
    Nutr Res; 2013 Mar; 33(3):171-9. PubMed ID: 23507222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visceral and central abdominal fat and anthropometry in relation to diabetes in Asian Indians.
    Anjana M; Sandeep S; Deepa R; Vimaleswaran KS; Farooq S; Mohan V
    Diabetes Care; 2004 Dec; 27(12):2948-53. PubMed ID: 15562212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioelectrical impedance outperforms waist circumference for predicting cardiometabolic risk in Congolese hypertensive subjects: a cross-sectional study.
    Katchunga PB; Bapolisi AM; M'Buyamba-Kabangu JR; Hermans MP
    BMC Cardiovasc Disord; 2015 Mar; 15():17. PubMed ID: 25887798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of total and visceral fat contents using anthropometric measures of adiposity in women.
    Weerarathna TP; Lekamwasam S; Rodrigo M
    Ceylon Med J; 2008 Dec; 53(4):128-32. PubMed ID: 19189790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical usefulness of abdominal bioimpedance (ViScan) in the determination of visceral fat and its application in the diagnosis and management of obesity and its comorbidities.
    Gómez-Ambrosi J; González-Crespo I; Catalán V; Rodríguez A; Moncada R; Valentí V; Romero S; Ramírez B; Silva C; Gil MJ; Salvador J; Benito A; Colina I; Frühbeck G
    Clin Nutr; 2018 Apr; 37(2):580-589. PubMed ID: 28187933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Body fat distribution as a risk factor for cerebrovascular disease: an MRI-based body fat quantification study.
    Karcher HS; Holzwarth R; Mueller HP; Ludolph AC; Huber R; Kassubek J; Pinkhardt EH
    Cerebrovasc Dis; 2013; 35(4):341-8. PubMed ID: 23615579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.